Item 1.01 Entry into a Material Definitive Agreement.
Stock Purchase Agreement
On
The Shares are being issued pursuant to the Company's registration statement on
Form S-3 (File No. 333-221285), as amended, which was declared effective by the
The Stock Purchase Agreement contains customary representations, warranties and covenants made by the Company.
The foregoing description of the Stock Purchase Agreement does not purport to be
complete and is qualified in its entirety by reference to the copy of the Stock
Purchase Agreement, which is filed as Exhibit 10.1 to this Current Report on
Form 8-K. A copy of the opinion of
The representations, warranties and covenants contained in the Stock Purchase
Agreement were made only for purposes of such agreement and as of specific
dates, were solely for the benefit of the parties to the Stock Purchase
Agreement, and may be subject to limitations agreed upon by the contracting
parties. Accordingly, the Stock Purchase Agreement is incorporated herein by
reference only to provide investors with information regarding the terms of the
Stock Purchase Agreement, and not to provide investors with any other factual
information regarding the Company or its business, and should be read in
conjunction with the disclosures in the Company's periodic reports and other
filings with the
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Number Description 5.1 Opinion ofBrownstein Hyatt Farber Schreck, LLP . 10.1 Stock Purchase Agreement, dated as ofJanuary 2, 2020 , by and betweenSeelos Therapeutics, Inc. andPhoenixus AG . 23.1 Consent ofBrownstein Hyatt Farber Schreck, LLP (included in Exhibit 5.1). * * * 2
--------------------------------------------------------------------------------
© Edgar Online, source